Anzeige
Mehr »
Freitag, 08.08.2025 - Börsentäglich über 12.000 News
Das Kupferangebot bricht ein - und dieser neue Fund kommt genau zur richtigen Zeit
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DEJC | ISIN: US03940C1009 | Ticker-Symbol:
NASDAQ
08.08.25 | 19:24
73,18 US-Dollar
+2,72 % +1,94
1-Jahres-Chart
ARCELLX INC Chart 1 Jahr
5-Tage-Chart
ARCELLX INC 5-Tage-Chart

Aktuelle News zur ARCELLX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoArcellx GAAP EPS of -$0.94 beats by $0.10, revenue of $7.55M misses by $6.37M1
ARCELLX Aktie jetzt für 0€ handeln
DoArcellx, Inc. - 8-K, Current Report-
31.07.4 Analysts Assess Arcellx: What You Need To Know2
08.07.Piper Sandler maintains Overweight rating on Arcellx stock amid CAR-T safety study6
17.06.Citi initiates Arcellx stock with buy rating on cell therapy potential3
16.06.Arcellx stock maintains buy rating at H.C. Wainwright on launch plans2
28.05.Arcellx, Inc. - 8-K, Current Report3
21.05.Arcellx, Inc.: Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025592Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced...
► Artikel lesen
20.05.Baron Discovery Fund Initiated a Position in Arcellx (ACLX)4
09.05.Arcellx GAAP EPS of -$1.13, revenue of $8.1M15
08.05.Arcellx, Inc. - 10-Q, Quarterly Report1
08.05.Arcellx, Inc. - 8-K, Current Report1
20.03.Arcellx names new board members, gears up for 2026 launch1
20.03.Arcellx, Inc. - 8-K, Current Report2
27.02.Arcellx GAAP EPS of -$2.00 misses by $0.40, revenue of $107.94M1
27.02.Arcellx, Inc. - 8-K, Current Report-
27.02.Arcellx, Inc. - 10-K, Annual Report-
07.11.24Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights726REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer...
► Artikel lesen
19.09.24ACLX, HROW Deliver Triple-Digit Returns - Did You Cash In?575WASHINGTON (dpa-AFX) - Many traders seek instant gratification in the stock market. Some stocks offer quick profits, while others require a patient, long-term approach for significant returns....
► Artikel lesen
08.08.24Arcellx Provides Second Quarter 2024 Financial Results and Business Updates385REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1